Protocol Summaries: levofloxacin
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| LEV102341 | phase 3 | A national, multicentric, randomised, controlled trial. Applications of a critical pathway using Levofloxacin for the management of patients with abnormal PSA. | Completed |